The market for GLP-1-specific nutrition products is completely unserved, representing a $400M+ immediate opportunity within a broader $3B+ addressable market
Start your intake What Ozempic actually is Ozempic is a brand name for semaglutide, a GLP-1 receptor agonist
Tirzepatide mimics and enhances the actions of two gut hormones: GLP-1 (glucagon-like peptide-1) : Helps regulate appetite, slow gastric emptying, and support insulin response GIP (glucose-dependent insulinotropic polypeptide) : Further supports metabolic balance and fullness By acting on both pathways, tirzepatide reduces hunger, increases feelings of fullness, and helps patients eat less without intense cravings
No clinically significant interactions have been identified between GLP-1-based medications and any statin
We've reviewed dozens of sexual medicine studies where investigators started subjects at 1.52mg because that's the dose range tanning studies used, then reported high dropout rates due to nausea and concluded MT-2 has poor tolerability